Buscar

Mostrando ítems 1-10 de 17

Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome

2019- Baluja González, María Aurora; Rodríguez Mañero, Moises; Cordero, A.; Kreidieh, B.; IGLESIAS ALVAREZ, DIEGO; [et al.]

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

2019- White, H. D.; Steg, P. G.; Szarek, M.; Bhatt, D. L.; Bittner, V. A.; [et al.]

Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature

2019- Rodríguez Mañero, Moises; Kreidieh, B.; Valderrabano, M.; Baluja González, María Aurora; Martínez Sande, Jose Luis; [et al.]

Refining the Predictive Potential of the Early Repolarization Pattern in Myocardial Infarction: An Elusive Endeavour

2019- Rodríguez Mañero, Moises; González Juanatey, José Ramón

Clinical impact of mineralocorticoid receptor antagonists treatment after acute coronary syndrome in the real world: A propensity score matching analysis

2019- AGRA BERMEJO, ROSA MARIA; Cordero, A.; Rodríguez Mañero, Moises; García Acuña, José María; Álvarez Álvarez, Belén; [et al.]

Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

2019- Steg, P. G.; Szarek, M.; Bhatt, D. L.; Bittner, V. A.; Bregeault, M. F.; [et al.]

Circulating Sphingosine-1-Phosphate as A Non-Invasive Biomarker of Heart Transplant Rejection

2019- Tarazon, E; Gil-Cayuela, C; Manzanares, MG; Roca, M; Lago Paz, Francisca; [et al.]

FNDC5/Irisin counteracts lipotoxic-induced apoptosis in hypoxic H9c2 cells

2019- Moscoso Galán, Isabel; Cebro Márquez, María; Rodríguez Mañero, Moises; González Juanatey, José Ramón; Lage Fernández, Ricardo

Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation A Report From the GARFIELD-AF Registry

2019- Corbalan, R.; Bassand, J. P.; Illingworth, L.; Ambrosio, G.; Camm, A. J.; [et al.]

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

2019- Roe, M. T.; Li, Q. H.; Bhatt, D. L.; Bittner, V. A.; Diaz, R.; [et al.]

1
2